Outlook Therapeutics Reports Financial Results for Fiscal Year 2025 ISELIN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for fiscal year 2025. Financial Highlights for the Fiscal Year Ended September 30, 2025 For the fiscal year ended September 30, 2025, Outlook Therapeutics reported net loss attributable to common stockholders of $62.4 million, or $1.79 per basic and diluted share, and $1.4 million of revenue. This com...
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing Co-Led by Commodore Capital, Perceptive Advisors and TCGX Supports Development of Lasofoxifene through Phase 3 Clinical Topline Data Readout and Regulatory Milestones Conference Call Today at 8:30 am Eastern Time BOTHELL, Wash., De...
Dime Community Bancshares Declares Quarterly Cash Dividend for Common Stock HAUPPAUGE, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (Nasdaq: DCOM) (the “Company”) announced that its Board of Directors declared a quarterly cash dividend of $0.25 per share of Common Stock, payable on January 23, 2026 to common stockholders of record as of January 16, 2026. The Company continues its trend of uninterrupted dividends. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartered trus...
Dime Awards Grant to Accompany Capital HAUPPAUGE, N.Y., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime has awarded a grant to Accompany Capital in support of their mission to help underserved entrepreneurs succeed by empowering them to create jobs, stimulate economic growth, and boost New York City communities. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartere...
Dime Announces Receipt of Federal Reserve and NYDFS Approvals for Locust Valley Branch Location HAUPPAUGE, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced it has received approvals from the Federal Reserve Bank of New York and the New York State Department of Financial Services to open a branch location in Locust Valley. The new branch, which will be located at 85 Forest Avenue, will be staffed by Liz Materia. Ms. Materia was previously a branch manager with...
Dime Awards Grant to Transitional Services for Long Island for Housing Services HAUPPAUGE, N.Y., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime has awarded a grant to Transitional Services for Long Island (“TSLI”). TSLI provides housing and support services to adults, families, and homeless individuals in Suffolk County. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York Stat...
Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference Live webcast fireside chat on Tuesday, December 2nd at 10:00 AM ET ISELIN, N.J., Nov. 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that Bob Jahr, Chief Executive Officer of Outlook Therapeutics, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 10:00 AM ET. In addition to the fireside chat,...
Dime Awards Grant to Long Island Cares HAUPPAUGE, N.Y., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime has awarded a grant to Long Island Cares in support of services to help the food insecure in Nassau and Suffolk counties. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartered trust company with over $14 billion in assets and the number one deposit market share ...
Dime Hires Dan Fosina To Lead New Jersey Middle Market Expansion Efforts HAUPPAUGE, N.Y., Nov. 21, 2025 (GLOBE NEWSWIRE) -- As part of the continued execution of its growth plan, Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced today that Dan Fosina will join Dime as Senior Vice President, Group Leader. Mr. Fosina will spearhead Dime’s middle market commercial banking expansion across the state of New Jersey. Stuart H. Lubow, President and Chief Executive Officer of Dime, said, "As part of our gro...
Dime Announces Plans to Open Locust Valley Branch Liz Materia Named Branch Manager HAUPPAUGE, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that, subject to the receipt of customary regulatory approvals, it plans to open a full-service branch location in Locust Valley in 2026. The new branch, which will be located at 85 Forest Avenue, will be staffed by Liz Materia. Ms. Materia was previously a branch manager with The First National Bank of Long Island, ...
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD Prescription Drug User Fee Act (PDUFA) goal date of December 31, 2025 ISELIN, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg), an investigational oph...
Dime Continues Partnership with Community Development of Long Island HAUPPAUGE, N.Y., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime is continuing its partnership with Community Development of Long Island (“CDLI”). CDLI is a not-for-profit organization that provides Long Island families with affordable housing, financial health, and wealth aspirations through education, home repair, and guidance. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Ban...
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update Continuing to explore strategic alternatives focusing on maximizing stockholder value Presented results from Phase 1 clinical trial of ATH-1105 in healthy volunteers demonstrating a favorable safety and tolerability profile as well as dose proportional pharmacokinetics and CNS penetration, supporting continued clinical development BOTHELL, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to...
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010 ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has re-submitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010, after receiving the official minutes from the FDA Type A meeting conducted in September 2025. ONS-5010 is an investigational ophthalmic formulation of bevacizumab which, if approved, will be br...
Dime Announces Senior Executive Succession Planning Positions Dime for Continued Growth HAUPPAUGE, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- As part of its senior executive succession planning, Dime Community Bancshares, Inc. (Nasdaq: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced the following: Conrad Gunther to retire at the end of 2025Thomas X. Geisel to assume Mr. Gunther’s responsibilities and appointed Chief Commercial OfficerAvi Reddy, current Chief Financial Officer, to take on additional title of Chief Operating Officer “Conra...
Dime Community Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock HAUPPAUGE, N.Y., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (Nasdaq: DCOM, DCOMP and DCOMG) (the “Company”) announced that its Board of Directors declared a quarterly cash dividend of $0.34375 per share on the Company’s 5.50% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A, payable on November 13, 2025 to holders of record as of November 6, 2025. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a...
Dime Community Bancshares, Inc. Reports 103% Year-Over-Year Increase in Earnings Per Share Quarterly Net Interest Margin Surpasses 3% And Is Anticipated to Increase Further in the Fourth Quarter Continued Strong Growth in Core Deposits and Business Loans HAUPPAUGE, N.Y., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), today reported net income available to common stockholders of $25.8 million for the quarter ended September 30, 2025, or $0.59 per diluted common share, comp...
Dime Community Bancshares to Release Earnings on October 23, 2025 HAUPPAUGE, N.Y., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the "Company") today announced that the Company expects to release its earnings for the quarter ended September 30, 2025 before the open of the U.S. equity markets on Thursday, October 23, 2025. The Company will conduct a conference call at 8:00 a.m. (ET) on Thursday, October 23, 2025, during which President and Chief Executive Officer (“CEO”), Stuart Lubow, will discuss the Company’s third quarter financial performance. There...
Dime Continues Support of Alzheimer’s Association HAUPPAUGE, N.Y., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime is continuing to support the Alzheimer’s Association. A team from the Bank will take part in the Walk to End Alzheimer’s on Long Island on October 4th, 2025. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartered trust company with over $14 billion in ...
Dime Sponsors AHA Long Island Heart Walk HAUPPAUGE, N.Y., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime sponsored the American Heart Association Heart Walk for 2025 on Long Island. Jeffrey Barber, Executive Vice President, was chosen as the Chairman of this year’s Heart Walk. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartered trust company with over $14 bill...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.